DALE G ANDO Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DALE G ANDO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DALE G ANDO. DALE G ANDO is V.P., Clinical Research in CELL GENESYS INC ($CEGE) and VP, Therapeutic Dev. & CMO in SANGAMO BIOSCIENCES INC ($SGMO).
Latest Insider Trading Transactions of DALE G ANDO
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Payment of Exercise | F | 8.68 | 4,000 | 34,720 | 107,328 | 111.3 K to 107.3 K (-3.59 %) |
| Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Payment of Exercise | F | 8.68 | 4,348 | 37,741 | 111,328 | 115.7 K to 111.3 K (-3.76 %) |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | A | 9.41 | 50,000 | 470,500 | 50,000 | |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Payment of Exercise | F | 9.69 | 6,087 | 58,983 | 115,676 | 121.8 K to 115.7 K (-5.00 %) |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Grant | A | 0.00 | 25,000 | 0 | 121,763 | 96.8 K to 121.8 K (+25.84 %) |
| Jun 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 15,000 | 51,750 | 50,798 | |
| Jun 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 12.29 | 15,000 | 184,394 | 96,763 | 111.8 K to 96.8 K (-13.42 %) |
| Jun 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 15,000 | 51,750 | 111,763 | 96.8 K to 111.8 K (+15.50 %) |
| May 05 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 15,000 | 51,750 | 65,798 | |
| May 05 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 12.29 | 15,000 | 184,298 | 95,376 | 110.4 K to 95.4 K (-13.59 %) |
| May 05 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 15,000 | 51,750 | 110,376 | 95.4 K to 110.4 K (+15.73 %) |
| Apr 08 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 15,000 | 51,750 | 80,798 | |
| Apr 08 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 14.94 | 15,000 | 224,172 | 95,376 | 110.4 K to 95.4 K (-13.59 %) |
| Apr 08 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 15,000 | 51,750 | 110,376 | 95.4 K to 110.4 K (+15.73 %) |
| Mar 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 15,000 | 51,750 | 95,798 | |
| Mar 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 18.29 | 15,000 | 274,283 | 95,376 | 110.4 K to 95.4 K (-13.59 %) |
| Mar 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 15,000 | 51,750 | 110,376 | 95.4 K to 110.4 K (+15.73 %) |
| Aug 04 2003 | CEGE | CELL GENESYS INC | ANDO DALE G | V.P., Clinical Rese ... | Buy | J | 8.08 | 785 | 6,346 | 9,600 | 8.8 K to 9.6 K (+8.91 %) |
Page: 1